project id: TCGA-BRCA; case submitter id: TCGA-BH-A8G0; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.56; rna integrity number: 8.3; age at index: 54; days to birth: -19975; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1958; age at diagnosis: 19975; ajcc pathologic m: M0; ajcc pathologic n: N1a; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 662.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8520/3; primary diagnosis: Lobular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 436; initial weight: 110.0; sample id: 75e9ad4a-ae3e-4331-9c35-0ce639ed3009; sample submitter id: TCGA-BH-A8G0-01A; portion id: 5fe23e30-38dd-49d9-aa46-2f76cb7efff8; portion submitter id: TCGA-BH-A8G0-01A-11; slide id: 27cbc599-7861-4307-beab-e0fbf50c96f7; slide submitter id: TCGA-BH-A8G0-01A-01-TSA; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 10.0; percent stromal cells: 30.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0; section location: TOP;